ReviewNAFLD: A multisystem disease
Under a Creative Commons license
open access
Abbreviations
AF
atrial fibrillation
ATGL
Adipose triglyceride lipase
AST/ALT
aspartate aminotransferase to alanine aminotransferase ratio
APRI
aspartate to platelet ratio index
CRP
C-reactive protein
CVD
cardiovascular disease
CGI-58
Comparative Gene Identification-58
CKD
chronic kidney disease
DAG
di-acyl glycerol
Di-P PA
di-palmitoyl phosphatidic acid
ELF
Enhanced Liver Fibrosis panel
FGF-21
fibroblast growth factor-21
FIB4
Fibrosis-4 Score
GFR
glomerular filtration rate
HCC
hepatocellular carcinoma
HF
heart failure
HR
hazard ratio
IRS-1
insulin receptor substrate-1
IL-6
interleukin 6
LCFAs
long chain fatty acids
LPA
lysophosphatidic acid
LV
left ventricular
MetS
metabolic syndrome
MRI
magnetic resonance imaging
MRS
magnetic resonance spectroscopy
NAFLD
non-alcoholic fatty liver disease
NHANES
National Health and Examination Survey
NASH
non-alcoholic steatohepatitis
NF-κB
nuclear factor-kappa B
OR
odds ratio
PTEN
phosphatase and tensin homolog
PA
phosphatidic acid
PAI-1
plasminogen activator inhibitor-1
PKCε
protein kinase Cε
T2DM
type 2 diabetes mellitus
TAG
triacylglycerol
TLR-4
toll-like receptor-4
TNF-α
tumour necrosis factor-α
VLDL
very-low-density lipoprotein
Keywords
Non-alcoholic fatty liver disease
Hepatocellular carcinoma
Type 2 diabetes
Insulin resistance
Cardiovascular disease
Cardiac disease
Cardiac arrhythmias
Chronic kidney disease
Cited by (0)
© 2014 European Association for the Study of the Liver. Published by Elsevier B.V.